-
Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.
J PediatrPetitti DB, Klingensmith GJ, Bell RA, Andrews JS, Dabelea D, Imperatore G, Marcovina S, Pihoker C, Standiford D, Waitzfelder B, Mayer-Davis E, SEARCH for Diabetes in Youth Study Group., Greenbaum CJ -
Preservation of beta-cell function in autoantibody-positive youth with diabetes.
Diabetes CareGreenbaum CJ, Anderson AM, Dolan LM, Mayer-Davis EJ, Dabelea D, Imperatore G, Marcovina S, Pihoker C, SEARCH Study Group. -
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.
Diabetes CareSosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. -
Changes in autoreactive T cell avidity during type 1 diabetes development.
Clin ImmunolStandifer NE, Burwell EA, Gersuk VH, Greenbaum CJ, Nepom GT -
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
Clin ImmunolHerold KC, Gitelman S, Greenbaum CJ, Puck J, Hagopian WA, Gottlieb PA, Sayre PH, Bianchine PJ, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA, Immune Tolerance Network ITN007AI Study Group. -
The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis.
J Clin Endocrinol MetabMa X, Becker D, Arena VC, Vicini P, Greenbaum CJ -
Type 1 Diabetes TrialNet--an international collaborative clinical trials network.
Ann N Y Acad SciSkyler JS, Greenbaum CJ, Lachin JM, Leschek E, Rafkin-Mervis L, Savage P, Spain L, Type 1 Diabetes TrialNet Study Group. -
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
J ImmunolSchneider A, Rieck M, Sanda S, Pihoker C, Greenbaum CJ, Buckner JH -
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Diabetes CareGreenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H, Type 1 Diabetes Trial Net Research Group., European C-Peptide Trial Study Group. -
CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.
J AutoimmunYang J, Danke N, Roti M, Huston L, Greenbaum CJ, Pihoker C , James EA, Kwok WW -
Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.
Mt Sinai J MedBollyky J, Sanda S, Greenbaum CJ -
Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study.
Arch Pediatr Adolesc MedNaughton MJ, Ruggiero AM, Lawrence JM, Imperatore G, Klingensmith GJ, Waitzfelder B, McKeown RE, Standiford DA, Liese AD, Loots B, SEARCH for Diabetes in Youth Study Group., Greenbaum CJ -
Standardization of C-peptide measurements.
Clin ChemLittle RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL, Greenbaum CJ, Palmer JP, Rogatsky E, Stein DT -
Use of oral glucose minimal model-derived index of insulin sensitivity in subjects with early type 1 diabetes mellitus.
MetabolismKrudys KM, Greenbaum CJ, Pihoker C, Vicini P -
A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.
Diabetes CareSosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group.
